The marine‐derived furanone reduces intracellular lipid accumulation in vitro by targeting LXRα and PPARα

Recent studies have demonstrated that commercially available lipid‐lowering drugs cause various side effects; therefore, searching for anti‐hyperlipidaemic compounds with lower toxicity is a research hotspot. This study was designed to investigate whether the marine‐derived compound, 5‐hydroxy‐3‐met...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ting, Hu, Shu‐Mei, Pang, Xiao‐Yan, Wang, Jun‐feng, Yin, Jia‐Yu, Li, Fa‐Hui, Wang, Jin, Yang, Xiao‐Qian, Xia, Bin, Liu, Yong‐Hong, Song, Wei‐Guo, Guo, Shou‐Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131916/
https://www.ncbi.nlm.nih.gov/pubmed/31981312
http://dx.doi.org/10.1111/jcmm.15012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131916/
https://www.ncbi.nlm.nih.gov/pubmed/31981312
http://dx.doi.org/10.1111/jcmm.15012

Ejemplares similares